NIAGEN BIOSCIENCE INC (NAGE) Fundamental Analysis & Valuation

NASDAQ:NAGE • US1710774076

Current stock price

4.93 USD
+0.2 (+4.23%)
At close:
4.9 USD
-0.03 (-0.61%)
After Hours:

This NAGE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. NAGE Profitability Analysis

1.1 Basic Checks

  • NAGE had positive earnings in the past year.
  • NAGE had a positive operating cash flow in the past year.
  • In multiple years NAGE reported negative net income over the last 5 years.
  • In multiple years NAGE reported negative operating cash flow during the last 5 years.
NAGE Yearly Net Income VS EBIT VS OCF VS FCFNAGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M

1.2 Ratios

  • NAGE's Return On Assets of 16.34% is amongst the best of the industry. NAGE outperforms 97.30% of its industry peers.
  • With an excellent Return On Equity value of 22.71%, NAGE belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.
  • NAGE's Return On Invested Capital of 13.06% is amongst the best of the industry. NAGE outperforms 86.49% of its industry peers.
Industry RankSector Rank
ROA 16.34%
ROE 22.71%
ROIC 13.06%
ROA(3y)6.62%
ROA(5y)-11.53%
ROE(3y)7.97%
ROE(5y)-23.86%
ROIC(3y)N/A
ROIC(5y)N/A
NAGE Yearly ROA, ROE, ROICNAGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • The Profit Margin of NAGE (13.43%) is better than 91.89% of its industry peers.
  • NAGE's Operating Margin of 11.05% is fine compared to the rest of the industry. NAGE outperforms 78.38% of its industry peers.
  • NAGE's Gross Margin of 64.28% is in line compared to the rest of the industry. NAGE outperforms 51.35% of its industry peers.
  • In the last couple of years the Gross Margin of NAGE has grown nicely.
Industry RankSector Rank
OM 11.05%
PM (TTM) 13.43%
GM 64.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.66%
GM growth 5Y1.55%
NAGE Yearly Profit, Operating, Gross MarginsNAGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. NAGE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NAGE is creating some value.
  • NAGE has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NAGE has been increased compared to 5 years ago.
  • There is no outstanding debt for NAGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NAGE Yearly Shares OutstandingNAGE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
NAGE Yearly Total Debt VS Total AssetsNAGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • NAGE has an Altman-Z score of 8.29. This indicates that NAGE is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 8.29, NAGE belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
  • NAGE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.29
ROIC/WACC1.46
WACC8.95%
NAGE Yearly LT Debt VS Equity VS FCFNAGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 4.86 indicates that NAGE has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.86, NAGE belongs to the top of the industry, outperforming 94.59% of the companies in the same industry.
  • NAGE has a Quick Ratio of 3.83. This indicates that NAGE is financially healthy and has no problem in meeting its short term obligations.
  • NAGE's Quick ratio of 3.83 is amongst the best of the industry. NAGE outperforms 89.19% of its industry peers.
Industry RankSector Rank
Current Ratio 4.86
Quick Ratio 3.83
NAGE Yearly Current Assets VS Current LiabilitesNAGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NAGE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 80.00% over the past year.
  • NAGE shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.95%.
  • The Revenue has been growing by 16.91% on average over the past years. This is quite good.
EPS 1Y (TTM)80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)29.95%
Revenue growth 3Y21.56%
Revenue growth 5Y16.91%
Sales Q2Q%16.19%

3.2 Future

  • Based on estimates for the next years, NAGE will show a very strong growth in Earnings Per Share. The EPS will grow by 41.50% on average per year.
  • NAGE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.19% yearly.
EPS Next Y54.42%
EPS Next 2Y39.82%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue Next Year16.14%
Revenue Next 2Y15.35%
Revenue Next 3Y18.19%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NAGE Yearly Revenue VS EstimatesNAGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
NAGE Yearly EPS VS EstimatesNAGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

5

4. NAGE Valuation Analysis

4.1 Price/Earnings Ratio

  • NAGE is valuated quite expensively with a Price/Earnings ratio of 27.39.
  • Compared to the rest of the industry, the Price/Earnings ratio of NAGE is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 27.42. NAGE is around the same levels.
  • NAGE is valuated rather expensively with a Price/Forward Earnings ratio of 17.74.
  • Based on the Price/Forward Earnings ratio, NAGE is valued a bit cheaper than 67.57% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of NAGE to the average of the S&P500 Index (22.24), we can say NAGE is valued slightly cheaper.
Industry RankSector Rank
PE 27.39
Fwd PE 17.74
NAGE Price Earnings VS Forward Price EarningsNAGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as NAGE.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as NAGE.
Industry RankSector Rank
P/FCF 29.88
EV/EBITDA 21.89
NAGE Per share dataNAGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NAGE has a very decent profitability rating, which may justify a higher PE ratio.
  • NAGE's earnings are expected to grow with 41.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y39.82%
EPS Next 3Y41.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NAGE Dividend Analysis

5.1 Amount

  • NAGE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NAGE Fundamentals: All Metrics, Ratios and Statistics

NIAGEN BIOSCIENCE INC

NASDAQ:NAGE (4/24/2026, 8:00:01 PM)

After market: 4.9 -0.03 (-0.61%)

4.93

+0.2 (+4.23%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners41.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner Change0.43%
Market Cap394.79M
Revenue(TTM)129.42M
Net Income(TTM)17.38M
Analysts85.45
Price Target13.87 (181.34%)
Short Float %10.38%
Short Ratio4.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)120.03%
Min EPS beat(2)33.69%
Max EPS beat(2)206.37%
EPS beat(4)4
Avg EPS beat(4)168.26%
Min EPS beat(4)33.69%
Max EPS beat(4)252.87%
EPS beat(8)8
Avg EPS beat(8)205.53%
EPS beat(12)12
Avg EPS beat(12)156.2%
EPS beat(16)14
Avg EPS beat(16)119.31%
Revenue beat(2)2
Avg Revenue beat(2)5.89%
Min Revenue beat(2)4.65%
Max Revenue beat(2)7.13%
Revenue beat(4)4
Avg Revenue beat(4)7.44%
Min Revenue beat(4)4.65%
Max Revenue beat(4)10.27%
Revenue beat(8)6
Avg Revenue beat(8)3.55%
Revenue beat(12)8
Avg Revenue beat(12)3.34%
Revenue beat(16)8
Avg Revenue beat(16)0.83%
PT rev (1m)-13.92%
PT rev (3m)-13.92%
EPS NQ rev (1m)10.71%
EPS NQ rev (3m)45.32%
EPS NY rev (1m)-7.63%
EPS NY rev (3m)-7.63%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-14.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.51%
Valuation
Industry RankSector Rank
PE 27.39
Fwd PE 17.74
P/S 3.05
P/FCF 29.88
P/OCF 29.24
P/B 5.16
P/tB 5.57
EV/EBITDA 21.89
EPS(TTM)0.18
EY3.65%
EPS(NY)0.28
Fwd EY5.64%
FCF(TTM)0.16
FCFY3.35%
OCF(TTM)0.17
OCFY3.42%
SpS1.62
BVpS0.96
TBVpS0.89
PEG (NY)0.5
PEG (5Y)N/A
Graham Number1.96739 (-60.09%)
Profitability
Industry RankSector Rank
ROA 16.34%
ROE 22.71%
ROCE 16.53%
ROIC 13.06%
ROICexc 51.69%
ROICexgc 69.75%
OM 11.05%
PM (TTM) 13.43%
GM 64.28%
FCFM 10.21%
ROA(3y)6.62%
ROA(5y)-11.53%
ROE(3y)7.97%
ROE(5y)-23.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.66%
GM growth 5Y1.55%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 37.2%
Cap/Sales 0.23%
Interest Coverage 14296
Cash Conversion 89.54%
Profit Quality 76.01%
Current Ratio 4.86
Quick Ratio 3.83
Altman-Z 8.29
F-Score6
WACC8.95%
ROIC/WACC1.46
Cap/Depr(3y)23.87%
Cap/Depr(5y)27.87%
Cap/Sales(3y)0.19%
Cap/Sales(5y)0.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y54.42%
EPS Next 2Y39.82%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue 1Y (TTM)29.95%
Revenue growth 3Y21.56%
Revenue growth 5Y16.91%
Sales Q2Q%16.19%
Revenue Next Year16.14%
Revenue Next 2Y15.35%
Revenue Next 3Y18.19%
Revenue Next 5YN/A
EBIT growth 1Y85.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.52%
OCF growth 3YN/A
OCF growth 5YN/A

NIAGEN BIOSCIENCE INC / NAGE Fundamental Analysis FAQ

What is the fundamental rating for NAGE stock?

ChartMill assigns a fundamental rating of 6 / 10 to NAGE.


What is the valuation status of NIAGEN BIOSCIENCE INC (NAGE) stock?

ChartMill assigns a valuation rating of 5 / 10 to NIAGEN BIOSCIENCE INC (NAGE). This can be considered as Fairly Valued.


How profitable is NIAGEN BIOSCIENCE INC (NAGE) stock?

NIAGEN BIOSCIENCE INC (NAGE) has a profitability rating of 6 / 10.


How financially healthy is NIAGEN BIOSCIENCE INC?

The financial health rating of NIAGEN BIOSCIENCE INC (NAGE) is 9 / 10.